inflammatory bowel diseases

Journal of medical Internet research

BMJ open

allergy and asthma proceedings

autophagy

[1] Endoscopic resection for non-polypoid dysplasia in inflammatory bowel disease: a systematic review protocol.

[2] Abstracts from the Eastern Allergy Conference, Palm Beach, Florida, May 30 to June 2, 2019.

[3] Using Twitter to Understand the Human Bowel Disease Community: Exploratory Analysis of Key Topics.

[4] Decreasing Colectomy Rate for Ulcerative Colitis in the United States Between 2007 and 2016: A Time Trend Analysis.

[5] New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.

[6] Thromboprophylaxis for Hospitalized Patients with Inflammatory Bowel Disease—Are We There Yet?

[7] crohn’s disease: a role of gut microbiota and nod2 gene polymorphisms in disease pathogenesis

[8] role of incretin axis in inflammatory bowel disease

[9] endoscopic diagnosis and differentiation of inflammatory bowel disease

[10] insights into the role of erysipelotrichaceae in the human host

[11] th17 cell and epithelial cell crosstalk during inflammatory bowel disease and carcinogenesis

[12] Rate of, Risk Factors for, and Interventions to Reduce Hospital Readmission in Patients with Inflammatory Bowel Diseases.

[13] Commentaries on "workshop report: Developing a pediatric inflammatory bowel diseases network and data platform in canada": International networking in pediatric gastroenterology research: Advancing science and medicine with collaborative efforts

[14] A Systematic Review of Case-Identification Algorithms Based on Italian Healthcare Administrative Databases for Three Relevant Diseases of the Digestive and Genitourinary System: Inflammatory Bowel Diseases, Celiac Disease, and Chronic Kidney Disease.

[15] Diet in treatment of Inflammatory Bowel Diseases.

[16] Safety of Janus Kinase Inhibitors in Patients with Inflammatory Bowel Diseases or Other Immune-mediated Diseases: a Systematic Review and Meta-Analysis.

[17] The Gut Microbiome in Inflammatory Bowel Diseases: Diagnostic and Therapeutic Implications.

[18] Regulation of Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κβ) in Inflammatory Bowel Diseases

[19] Inflammatory bowel diseases: IL-12/IL-23 inhibitor shows effectiveness and tolerability also in clinical practice

[20] Corona Virus Disease 2019 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology, and Nutrition.

[21] lifestyle issues in children and adolescents with chronic inflammatory bowel diseases

[22] frequency and significance of the novel single nucleotide missense polymorphism val109asp in the human gene encoding omentin in caucasian patients with type 2 diabetes mellitus or chronic inflammatory bowel diseases

[23] vedolizumab in patients with inflammatory bowel diseases of in real clinical practice

[24] defb1 gene 5' untranslated region (utr) polymorphisms in inflammatory bowel diseases

[25] the impact of glutathione s–transferase genotype and phenotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases

[26] exercise in patients with inflammatory bowel diseases: current perspectives

[27] tumor necrosis factor receptor superfamily, member 1b haplotypes increase or decrease the risk of inflammatory bowel diseases in a new zealand caucasian population

[28] application of 5-aminosalicylic acid preparations in the treatment of inflammatory bowel diseases

[29] development and validation of an administrative case definition for inflammatory bowel diseases

[30] Rapid Response to Vedolizumab Therapy in Biologic-Naive Patients With Inflammatory Bowel Diseases

[31] Epidemiology of Inflammatory Bowel Diseases in Iran and Asia; A Mini Review

[32] Anti-IL-6 Treatment for Inflammatory Bowel Diseases: Next Cytokine, Next Target